You are viewing an incomplete version of our website. Please click to reload the website as full version.

Glutathione S Transferase (GST) (Active) Protein

Details for Product No. ABIN413895, Supplier: Login to see
Protein Name
  • GST
  • GST 13-13
  • GST13
  • GST13-13
  • GSTK1-1
  • hGSTK1
  • GSTS
  • GSTS1-1
  • PGD2
  • PGDS
  • H-PGDS
  • Ptgds2
  • 1500002K10Rik
  • Gst
Origin
Horse (Equine)
10
4
4
2
2
1
1
1
1
1
1
1
1
1
1
Source
Horse
18
10
1
1
1
Protein Type
Native
Biological Activity
Active
Application
Functional Studies (Func), SDS-PAGE (SDS), Western Blotting (WB)
Supplier
Login to see
Supplier Product No.
Login to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Purpose Pure Active GST protein, for positive control in GST activity assay or for screening GST inhibitors.
Characteristics Protein Source: Purified from equine liver
Purification Purified from equine liver
Background As a positive control in GST activity assay or for screening GST inhibitors. Refer to the GST Fluorometric and Colorimetric Assay Kits for detailed assay procedures .
Alternate Names: GST, Glutathione S-Transferase, Glutathione Transferase
Molecular Weight 45 - 50 kDa
CAS-No 50812-37-8
Research Area Metabolism, Immunology
Pathways
Application Notes As a positive control in GST activity assay or for screening GST inhibitors. Refer to the GST Fluorometric and Colorimetric Assay Kits for detailed assay procedures.
Optimal working dilution should be determined by the investigator.
Comment

Activity Specification: 50-100 units/mg protein

Restrictions For Research Use only
Format Lyophilized
Buffer Lyophilized powder
Handling Advice Centrifuge the vial prior to opening.
Storage -20 °C
Storage Comment -20°C
Expiry Date 12 months
Product cited in: Ji, Tulin: "Poly(ADP-ribosyl)ation of heterogeneous nuclear ribonucleoproteins modulates splicing." in: Nucleic acids research, Vol. 37, Issue 11, pp. 3501-13, 2009 (PubMed).

Candelario-Jalil, Taheri, Yang et al.: "Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat." in: The Journal of pharmacology and experimental therapeutics, Vol. 323, Issue 2, pp. 488-98, 2007 (PubMed).